Terms: = Kidney tumors AND RET, RET51, 5979, P07949, ENSG00000165731, MTC1, MEN2A, RET-ELE1, HSCR1, MEN2B, CDHF12 AND Prognosis
3 results:
1. Sorafenib in Metastatic Papillary Thyroid Carcinoma with
Caterino M; Pirozzi M; Facchini S; Zotta A; Sica A; Lo Giudice G; Rauso R; Varriale E; Ciardiello F; Fasano M
Medicina (Kaunas); 2022 May; 58(5):. PubMed ID: 35630083
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic and Predictive Values of Subcellular Localisation of ret in Renal Clear-Cell Carcinoma.
Wang L; Zhang Y; Gao Y; Fan Y; Chen L; Liu K; Meng Q; Zhao C; Ma X
Dis Markers; 2016; 2016():6870470. PubMed ID: 27092013
[TBL] [Abstract] [Full Text] [Related]
3. Antibody therapy to human L1CAM in a transgenic mouse model blocks local tumor growth but induces EMT.
Doberstein K; Harter PN; Haberkorn U; Bretz NP; Arnold B; Carretero R; Moldenhauer G; Mittelbronn M; Altevogt P
Int J Cancer; 2015 Mar; 136(5):E326-39. PubMed ID: 25230579
[TBL] [Abstract] [Full Text] [Related]